Cargando…

Desire for predictive testing for Alzheimer’s disease and impact on advance care planning: a cross-sectional study

BACKGROUND: It is unknown whether older adults in the United States would be willing to take a test predictive of future Alzheimer’s disease, or whether testing would change behavior. Using a nationally representative sample, we explored who would take a free and definitive test predictive of Alzhei...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheffrin, Meera, Stijacic Cenzer, Irena, Steinman, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153917/
https://www.ncbi.nlm.nih.gov/pubmed/27955707
http://dx.doi.org/10.1186/s13195-016-0223-9
_version_ 1782474791151730688
author Sheffrin, Meera
Stijacic Cenzer, Irena
Steinman, Michael A.
author_facet Sheffrin, Meera
Stijacic Cenzer, Irena
Steinman, Michael A.
author_sort Sheffrin, Meera
collection PubMed
description BACKGROUND: It is unknown whether older adults in the United States would be willing to take a test predictive of future Alzheimer’s disease, or whether testing would change behavior. Using a nationally representative sample, we explored who would take a free and definitive test predictive of Alzheimer’s disease, and examined how using such a test may impact advance care planning. METHODS: A cross-sectional study within the 2012 Health and Retirement Study of adults aged 65 years or older asked questions about a test predictive of Alzheimer’s disease (N = 874). Subjects were asked whether they would want to take a hypothetical free and definitive test predictive of future Alzheimer’s disease. Then, imagining they knew they would develop Alzheimer’s disease, subjects rated the chance of completing advance care planning activities from 0 to 100. We classified a score > 50 as being likely to complete that activity. We evaluated characteristics associated with willingness to take a test for Alzheimer’s disease, and how such a test would impact completing an advance directive and discussing health plans with loved ones. RESULTS: Overall, 75% (N = 648) of the sample would take a free and definitive test predictive of Alzheimer’s disease. Older adults willing to take the test had similar race and educational levels to those who would not, but were more likely to be ≤75 years old (odds ratio 0.71 (95% CI 0.53–0.94)). Imagining they knew they would develop Alzheimer’s, 81% would be likely to complete an advance directive, although only 15% had done so already. CONCLUSIONS: In this nationally representative sample, 75% of older adults would take a free and definitive test predictive of Alzheimer’s disease. Many participants expressed intent to increase activities of advance care planning with this knowledge. This confirms high public interest in predictive testing for Alzheimer’s disease and suggests this may be an opportunity to engage patients in advance care planning discussions.
format Online
Article
Text
id pubmed-5153917
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51539172016-12-20 Desire for predictive testing for Alzheimer’s disease and impact on advance care planning: a cross-sectional study Sheffrin, Meera Stijacic Cenzer, Irena Steinman, Michael A. Alzheimers Res Ther Research BACKGROUND: It is unknown whether older adults in the United States would be willing to take a test predictive of future Alzheimer’s disease, or whether testing would change behavior. Using a nationally representative sample, we explored who would take a free and definitive test predictive of Alzheimer’s disease, and examined how using such a test may impact advance care planning. METHODS: A cross-sectional study within the 2012 Health and Retirement Study of adults aged 65 years or older asked questions about a test predictive of Alzheimer’s disease (N = 874). Subjects were asked whether they would want to take a hypothetical free and definitive test predictive of future Alzheimer’s disease. Then, imagining they knew they would develop Alzheimer’s disease, subjects rated the chance of completing advance care planning activities from 0 to 100. We classified a score > 50 as being likely to complete that activity. We evaluated characteristics associated with willingness to take a test for Alzheimer’s disease, and how such a test would impact completing an advance directive and discussing health plans with loved ones. RESULTS: Overall, 75% (N = 648) of the sample would take a free and definitive test predictive of Alzheimer’s disease. Older adults willing to take the test had similar race and educational levels to those who would not, but were more likely to be ≤75 years old (odds ratio 0.71 (95% CI 0.53–0.94)). Imagining they knew they would develop Alzheimer’s, 81% would be likely to complete an advance directive, although only 15% had done so already. CONCLUSIONS: In this nationally representative sample, 75% of older adults would take a free and definitive test predictive of Alzheimer’s disease. Many participants expressed intent to increase activities of advance care planning with this knowledge. This confirms high public interest in predictive testing for Alzheimer’s disease and suggests this may be an opportunity to engage patients in advance care planning discussions. BioMed Central 2016-12-13 /pmc/articles/PMC5153917/ /pubmed/27955707 http://dx.doi.org/10.1186/s13195-016-0223-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Sheffrin, Meera
Stijacic Cenzer, Irena
Steinman, Michael A.
Desire for predictive testing for Alzheimer’s disease and impact on advance care planning: a cross-sectional study
title Desire for predictive testing for Alzheimer’s disease and impact on advance care planning: a cross-sectional study
title_full Desire for predictive testing for Alzheimer’s disease and impact on advance care planning: a cross-sectional study
title_fullStr Desire for predictive testing for Alzheimer’s disease and impact on advance care planning: a cross-sectional study
title_full_unstemmed Desire for predictive testing for Alzheimer’s disease and impact on advance care planning: a cross-sectional study
title_short Desire for predictive testing for Alzheimer’s disease and impact on advance care planning: a cross-sectional study
title_sort desire for predictive testing for alzheimer’s disease and impact on advance care planning: a cross-sectional study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153917/
https://www.ncbi.nlm.nih.gov/pubmed/27955707
http://dx.doi.org/10.1186/s13195-016-0223-9
work_keys_str_mv AT sheffrinmeera desireforpredictivetestingforalzheimersdiseaseandimpactonadvancecareplanningacrosssectionalstudy
AT stijaciccenzerirena desireforpredictivetestingforalzheimersdiseaseandimpactonadvancecareplanningacrosssectionalstudy
AT steinmanmichaela desireforpredictivetestingforalzheimersdiseaseandimpactonadvancecareplanningacrosssectionalstudy